The ePlex BCID-GP Control M323 v1.1 is intended for use as an external positive and negative quality control to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of the gram-positive pathogens, pan targets, and resistance genes on the ePlex System (GenMark Diagnostics, Inc.). The ePlex BCID-GP Control M323 v1.1 is composed of synthetic DNA specifically designed for and intended to be used solely with the ePlex BCID-GP Panel assay. ePlex BCID-GP Control M323 v1.1 is composed of 4 controls, ePlex BCID-GP Positive A, ePlex BCID-GP Positive B1, ePlex BCID-GP Positive C, and ePlex BCID-GP Negative. ePlex BCID-GP Control M323 v1.1 is comprised of 12 tubes, 3 tubes of each positive control, A, B1, and C, and 3 tubes of negative control, 50μL each.